Fecal microbiota transplantation: Past, present and future

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases. RECENT FINDINGS: It is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders. SUMMARY: FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.

Original languageEnglish (US)
Pages (from-to)79-84
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume29
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Clostridium Infections
Clostridium difficile
Irritable Bowel Syndrome
Inflammatory Bowel Diseases
Chronic Fatigue Syndrome
Gastrointestinal Diseases
Microbiota
Health
Constipation
Cellular Immunity
Energy Metabolism
Autoimmune Diseases
Fecal Microbiota Transplantation
Obesity
Gastrointestinal Microbiome
Therapeutics

Keywords

  • Clostridium difficile infection
  • fecal microbiota transplantation
  • inflammatory bowel disease
  • irritable bowel syndrome
  • obesity

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Fecal microbiota transplantation : Past, present and future. / Aroniadis, Olga C.; Brandt, Lawrence J.

In: Current Opinion in Gastroenterology, Vol. 29, No. 1, 01.2013, p. 79-84.

Research output: Contribution to journalArticle

@article{5da65a14e5db43cb915a0211815ef462,
title = "Fecal microbiota transplantation: Past, present and future",
abstract = "PURPOSE OF REVIEW: Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases. RECENT FINDINGS: It is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders. SUMMARY: FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.",
keywords = "Clostridium difficile infection, fecal microbiota transplantation, inflammatory bowel disease, irritable bowel syndrome, obesity",
author = "Aroniadis, {Olga C.} and Brandt, {Lawrence J.}",
year = "2013",
month = "1",
doi = "10.1097/MOG.0b013e32835a4b3e",
language = "English (US)",
volume = "29",
pages = "79--84",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Fecal microbiota transplantation

T2 - Past, present and future

AU - Aroniadis, Olga C.

AU - Brandt, Lawrence J.

PY - 2013/1

Y1 - 2013/1

N2 - PURPOSE OF REVIEW: Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases. RECENT FINDINGS: It is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders. SUMMARY: FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.

AB - PURPOSE OF REVIEW: Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases. RECENT FINDINGS: It is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders. SUMMARY: FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.

KW - Clostridium difficile infection

KW - fecal microbiota transplantation

KW - inflammatory bowel disease

KW - irritable bowel syndrome

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=84871638124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871638124&partnerID=8YFLogxK

U2 - 10.1097/MOG.0b013e32835a4b3e

DO - 10.1097/MOG.0b013e32835a4b3e

M3 - Article

C2 - 23041678

AN - SCOPUS:84871638124

VL - 29

SP - 79

EP - 84

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 1

ER -